Integrative inflammasome activity in the regulation of intestinal mucosal immune responses

[1]  H. Okamura,et al.  IL18 polymorphism is associated with an increased risk of Crohn’s disease , 2002, Journal of Gastroenterology.

[2]  L. Peyrin-Biroulet,et al.  Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  H. Herfarth,et al.  NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. , 2012, Immunity.

[4]  B. Finlay,et al.  Role of Inflammasomes in Host Defense against Citrobacter rodentium Infection* , 2012, The Journal of Biological Chemistry.

[5]  Moshe Arditi,et al.  Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. , 2012, Immunity.

[6]  E. Elinav,et al.  Inflammasomes: far beyond inflammation , 2012, Nature Immunology.

[7]  G. Núñez,et al.  Sensing and reacting to microbes through the inflammasomes , 2012, Nature Immunology.

[8]  R. Vance,et al.  Lethal inflammasome activation by a multi-drug resistant pathobiont upon antibiotic disruption of the microbiota , 2012, Nature Medicine.

[9]  G. Núñez,et al.  NLRC4-driven interleukin-1β production discriminates between pathogenic and commensal bacteria and promotes host intestinal defense , 2012, Nature Immunology.

[10]  Richard A. Flavell,et al.  Inflammasomes in health and disease , 2012, Nature.

[11]  Richard A. Flavell,et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.

[12]  P. Hylemon,et al.  Linkage of gut microbiome with cognition in hepatic encephalopathy. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[13]  D. Green,et al.  The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. , 2011, Cancer cell.

[14]  Jinfeng Liu,et al.  Non-canonical inflammasome activation targets caspase-11 , 2011, Nature.

[15]  Hao Xu,et al.  The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus , 2011, Nature.

[16]  R. Vance,et al.  Innate immune recognition of bacterial ligands by NAIPs dictates inflammasome specificity , 2011, Nature.

[17]  Richard A Flavell,et al.  Inflammasome-mediated suppression of inflammation-induced colorectal cancer progression is mediated by direct regulation of epithelial cell proliferation , 2011, Cell cycle.

[18]  J. Bertin,et al.  A Functional Role for Nlrp6 in Intestinal Inflammation and Tumorigenesis , 2011, The Journal of Immunology.

[19]  F. Bredin,et al.  Genetic association between NLRP3 variants and Crohn's disease does not replicate in a large UK panel , 2011, Inflammatory bowel diseases.

[20]  Yan Li,et al.  NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis , 2011, Inflammatory bowel diseases.

[21]  Richard A. Flavell,et al.  NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.

[22]  B. Chandran,et al.  IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. , 2011, Cell host & microbe.

[23]  M. Chamaillard,et al.  Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury , 2011, Proceedings of the National Academy of Sciences.

[24]  Sky W. Brubaker,et al.  Differential Requirements for NAIP5 in Activation of the NLRC4 Inflammasome , 2011, Infection and Immunity.

[25]  E. Elinav,et al.  Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4 , 2010, Proceedings of the National Academy of Sciences.

[26]  A. Aderem,et al.  Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria , 2010, Nature Immunology.

[27]  M. Lamkanfi,et al.  IL-18 Production Downstream of the Nlrp3 Inflammasome Confers Protection against Colorectal Tumor Formation , 2010, The Journal of Immunology.

[28]  F. Marincola,et al.  MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18 , 2010, The Journal of experimental medicine.

[29]  V. Dixit,et al.  Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella , 2010, The Journal of experimental medicine.

[30]  H. Herfarth,et al.  The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer , 2010, The Journal of experimental medicine.

[31]  J. Tschopp,et al.  Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome , 2010, Gut.

[32]  Jongdae Lee,et al.  ERK activation drives intestinal tumorigenesis in Apcmin/+ mice , 2010, Nature Medicine.

[33]  N. Beauchemin,et al.  Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. , 2010, Immunity.

[34]  M. Kastan,et al.  The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. , 2010, Immunity.

[35]  B. Siegmund.  Interleukin-18 in intestinal inflammation: friend and foe? , 2010, Immunity.

[36]  Richard Bonneau,et al.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome , 2010, Proceedings of the National Academy of Sciences.

[37]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[38]  J. Tschopp,et al.  The Inflammasomes , 2010, Cell.

[39]  M. Heikenwalder,et al.  The S. Typhimurium effector SopE induces caspase-1 activation in stromal cells to initiate gut inflammation. , 2009, Cell host & microbe.

[40]  Jasmyn A. Dunn,et al.  HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA , 2009, Science.

[41]  M. Karin,et al.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. , 2009, Cancer cell.

[42]  Ozge Canli,et al.  gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. , 2009, Cancer cell.

[43]  E. Alnemri,et al.  AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA , 2009, Nature.

[44]  Daniel R. Caffrey,et al.  AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC , 2009, Nature.

[45]  Charles Giardina,et al.  Mouse models for the study of colon carcinogenesis. , 2008, Carcinogenesis.

[46]  Mathieu Lemire,et al.  Common variants in the NLRP3 region contribute to Crohn's disease susceptibility , 2009, Nature Genetics.

[47]  Sky W. Brubaker,et al.  Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin , 2008, Nature Immunology.

[48]  M Ojima,et al.  Relationship of Porphyromonas gingivalis with glycemic level in patients with type 2 diabetes following periodontal treatment. , 2008, Oral microbiology and immunology.

[49]  K. Rock,et al.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.

[50]  V. Nizet,et al.  A Nod2–nalp1 Complex Mediates Caspase-1-dependent Il-1␤ Secretion in Response to Bacillus Anthracis Infection and Muramyl Dipeptide Nod2, a Nod-like Receptor (nlr), Is an Intracellular Sensor of Bacterial Muramyl Dipeptide (mdp) That Was Suggested to Promote Secretion of the Proinflammatory Cytokine , 2022 .

[51]  A. Zhernakova,et al.  Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. , 2008, American journal of human genetics.

[52]  N. Mukaida,et al.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. , 2008, The Journal of clinical investigation.

[53]  F. Schmidt.  Meta-Analysis , 2008 .

[54]  C. Sasakawa,et al.  Differential Regulation of Caspase-1 Activation, Pyroptosis, and Autophagy via Ipaf and ASC in Shigella-Infected Macrophages , 2007, PLoS pathogens.

[55]  R. Medzhitov,et al.  Regulation of Spontaneous Intestinal Tumorigenesis Through the Adaptor Protein MyD88 , 2007, Science.

[56]  H. Lehr,et al.  The ICE Inhibitor Pralnacasan Prevents DSS-Induced Colitis in C57BL/6 Mice and Suppresses IP-10 mRNA but Not TNF-α mRNA Expression , 2007, Digestive Diseases and Sciences.

[57]  J. Ting,et al.  Cutting Edge: Monarch-1 Suppresses Non-Canonical NF-κB Activation and p52-Dependent Chemokine Expression in Monocytes1 , 2007, The Journal of Immunology.

[58]  J. Ting,et al.  Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. , 2007, Journal of immunology.

[59]  A. Zychlinsky,et al.  Caspase-1-Mediated Activation of Interleukin-1β (IL-1β) and IL-18 Contributes to Innate Immune Defenses against Salmonella enterica Serovar Typhimurium Infection , 2006, Infection and Immunity.

[60]  J. Bertin,et al.  Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis , 2006, The Journal of experimental medicine.

[61]  J. Bertin,et al.  Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages , 2006, Nature Immunology.

[62]  J. Bertin,et al.  Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. , 2006, Immunity.

[63]  T. Tomita,et al.  Association Between Il‐18 Gene Promoter Polymorphisms and Inflammatory Bowel Disease in a Japanese Population , 2005, Inflammatory bowel diseases.

[64]  T. Sørensen,et al.  Increased Risk of Intestinal Cancer in Crohn's Disease: A Meta-Analysis of Population-Based Cohort Studies , 2005, The American Journal of Gastroenterology.

[65]  Stefan Wirtz,et al.  TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling , 2004 .

[66]  R. Kiesslich,et al.  TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. , 2004, Immunity.

[67]  Michael Karin,et al.  IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.

[68]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[69]  H. Lehr,et al.  The Interleukin-1β-Converting Enzyme Inhibitor Pralnacasan Reduces Dextran Sulfate Sodium-Induced Murine Colitis and T Helper 1 T-Cell Activation , 2004, Journal of Pharmacology and Experimental Therapeutics.

[70]  H. Lehr,et al.  The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation. , 2004, The Journal of pharmacology and experimental therapeutics.

[71]  S. Akira,et al.  Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. , 2003, Scandinavian journal of gastroenterology.

[72]  T. Hibi,et al.  Interleukin‐18 overproduction exacerbates the development of colitis with markedly infiltrated macrophages in interleukin‐18 transgenic mice , 2003, Journal of gastroenterology and hepatology.

[73]  J. Bertin,et al.  Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF‐κB and caspase‐1 , 2002, FEBS letters.

[74]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[75]  M. Neurath,et al.  Treatment of T Cell-Dependent Experimental Colitis in SCID Mice by Local Administration of an Adenovirus Expressing IL-18 Antisense mRNA1 , 2002, The Journal of Immunology.

[76]  G. Fantuzzi,et al.  IL-1β-converting enzyme (caspase-1) in intestinal inflammation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[77]  S. Akira,et al.  Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. , 2001, Gastroenterology.

[78]  G. Fantuzzi,et al.  Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-γ and TNF-α production , 2001 .

[79]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[80]  G. Fantuzzi,et al.  Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[81]  G. Fantuzzi,et al.  IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[82]  T. Hibi,et al.  Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease. , 2000, Gastroenterology.

[83]  C. Moskaluk,et al.  IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. , 1998, Journal of immunology.

[84]  A. Moser,et al.  Intestinal neoplasia in the ApcMin mouse: independence from the microbial and natural killer (beige locus) status. , 1997, Cancer research.

[85]  John Saunders,et al.  Friend and Foe , 1890, The Hospital.